To understand the roles and potential molecular mechanisms of IL-17A in Ph+ B-ALL cells, we performed RNA sequencing (RNA-seq) and analyzed the gene expression profiles of primary mouse Ph+ B-ALL cells with or without recombinant mouse IL-17A (rmIL-17A) treatment (Fig. 4a). This evidence concerns the gene IL17A and acute lymphoblastic leukemia.